Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.

Graham J. Kemp, Peter S. Rose, John R. Lurain et al. · Journal of Clinical Oncology · 1996 · 469 citations

Medicine, Oncology, Pharmacology +17

Evaluation of long-term toxicity after chemotherapy for testicular cancer.

Carsten Bokemeyer, C. Berger, M. Kuczyk et al. · Journal of Clinical Oncology · 1996 · 268 citations

Medicine, Oncology, Pharmacology +15

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.

W. Siegert, J. Beyer, Imke Strohscheer et al. · Journal of Clinical Oncology · 1994 · 226 citations

Pharmacy, Oncology, Pharmacotherapy +16

Salvage Treatment With Paclitaxel, Ifosfamide, and Cisplatin Plus High-Dose Carboplatin, Etoposide, and Thiotepa Followed by Autologous Stem-Cell Rescue in Patients With Relapsed or Refractory Germ Cell Cancer

Oliver Rick, Carsten Bokemeyer, J. Beyer et al. · Journal of Clinical Oncology · 2001 · 140 citations

Medicine, Oncology, Pharmacotherapy +17

Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy.

Marshall P. Goren, Reba K. Wright, Charles B. Pratt et al. · PubMed · 1987 · 112 citations

Medicine, Oncology, Toxicology +16